← Evidence map

ReviewOncoTargets and therapy2020

Adverse Effects of Immune-Checkpoint Inhibitors in Hepatocellular Carcinoma.

Tian-Ming Cui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

35 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled itcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 33235462